Assessing the causal association of glycine with risk of cardio-metabolic diseases
Circulating levels of glycine have previously been associated with lower incidence of coronary heart disease (CHD) and type 2 diabetes (T2D) but it remains uncertain if glycine plays an aetiological role. We present a meta-analysis of genome-wide association studies for glycine in 80,003 participant...
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Nature Research
2019
|
_version_ | 1826259621352833024 |
---|---|
author | Wittemans, L Lotta, L Oliver-Williams, C Stewart, I Surendran, P Karthikeyan, S Day, F Koulman, A Imamura, F Zeng, L Erdmann, J Schunkert, H Khaw, K Griffin, J Forouhi, N Scott, R Wood, A Burgess, S Howson, J Danesh, J Wareham, N Butterworth, A Langenberg, C |
author_facet | Wittemans, L Lotta, L Oliver-Williams, C Stewart, I Surendran, P Karthikeyan, S Day, F Koulman, A Imamura, F Zeng, L Erdmann, J Schunkert, H Khaw, K Griffin, J Forouhi, N Scott, R Wood, A Burgess, S Howson, J Danesh, J Wareham, N Butterworth, A Langenberg, C |
author_sort | Wittemans, L |
collection | OXFORD |
description | Circulating levels of glycine have previously been associated with lower incidence of coronary heart disease (CHD) and type 2 diabetes (T2D) but it remains uncertain if glycine plays an aetiological role. We present a meta-analysis of genome-wide association studies for glycine in 80,003 participants and investigate the causality and potential mechanisms of the association between glycine and cardio-metabolic diseases using genetic approaches. We identify 27 genetic loci, of which 22 have not previously been reported for glycine. We show that glycine is genetically associated with lower CHD risk and find that this may be partly driven by blood pressure. Evidence for a genetic association of glycine with T2D is weaker, but we find a strong inverse genetic effect of hyperinsulinaemia on glycine. Our findings strengthen evidence for a protective effect of glycine on CHD and show that the glycine-T2D association may be driven by a glycine-lowering effect of insulin resistance. |
first_indexed | 2024-03-06T18:52:45Z |
format | Journal article |
id | oxford-uuid:10ce9c01-a3d4-45f0-8ca9-d1c497a96f1b |
institution | University of Oxford |
language | English |
last_indexed | 2024-03-06T18:52:45Z |
publishDate | 2019 |
publisher | Nature Research |
record_format | dspace |
spelling | oxford-uuid:10ce9c01-a3d4-45f0-8ca9-d1c497a96f1b2022-03-26T09:58:32ZAssessing the causal association of glycine with risk of cardio-metabolic diseasesJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:10ce9c01-a3d4-45f0-8ca9-d1c497a96f1bEnglishSymplectic Elements at OxfordNature Research2019Wittemans, LLotta, LOliver-Williams, CStewart, ISurendran, PKarthikeyan, SDay, FKoulman, AImamura, FZeng, LErdmann, JSchunkert, HKhaw, KGriffin, JForouhi, NScott, RWood, ABurgess, SHowson, JDanesh, JWareham, NButterworth, ALangenberg, CCirculating levels of glycine have previously been associated with lower incidence of coronary heart disease (CHD) and type 2 diabetes (T2D) but it remains uncertain if glycine plays an aetiological role. We present a meta-analysis of genome-wide association studies for glycine in 80,003 participants and investigate the causality and potential mechanisms of the association between glycine and cardio-metabolic diseases using genetic approaches. We identify 27 genetic loci, of which 22 have not previously been reported for glycine. We show that glycine is genetically associated with lower CHD risk and find that this may be partly driven by blood pressure. Evidence for a genetic association of glycine with T2D is weaker, but we find a strong inverse genetic effect of hyperinsulinaemia on glycine. Our findings strengthen evidence for a protective effect of glycine on CHD and show that the glycine-T2D association may be driven by a glycine-lowering effect of insulin resistance. |
spellingShingle | Wittemans, L Lotta, L Oliver-Williams, C Stewart, I Surendran, P Karthikeyan, S Day, F Koulman, A Imamura, F Zeng, L Erdmann, J Schunkert, H Khaw, K Griffin, J Forouhi, N Scott, R Wood, A Burgess, S Howson, J Danesh, J Wareham, N Butterworth, A Langenberg, C Assessing the causal association of glycine with risk of cardio-metabolic diseases |
title | Assessing the causal association of glycine with risk of cardio-metabolic diseases |
title_full | Assessing the causal association of glycine with risk of cardio-metabolic diseases |
title_fullStr | Assessing the causal association of glycine with risk of cardio-metabolic diseases |
title_full_unstemmed | Assessing the causal association of glycine with risk of cardio-metabolic diseases |
title_short | Assessing the causal association of glycine with risk of cardio-metabolic diseases |
title_sort | assessing the causal association of glycine with risk of cardio metabolic diseases |
work_keys_str_mv | AT wittemansl assessingthecausalassociationofglycinewithriskofcardiometabolicdiseases AT lottal assessingthecausalassociationofglycinewithriskofcardiometabolicdiseases AT oliverwilliamsc assessingthecausalassociationofglycinewithriskofcardiometabolicdiseases AT stewarti assessingthecausalassociationofglycinewithriskofcardiometabolicdiseases AT surendranp assessingthecausalassociationofglycinewithriskofcardiometabolicdiseases AT karthikeyans assessingthecausalassociationofglycinewithriskofcardiometabolicdiseases AT dayf assessingthecausalassociationofglycinewithriskofcardiometabolicdiseases AT koulmana assessingthecausalassociationofglycinewithriskofcardiometabolicdiseases AT imamuraf assessingthecausalassociationofglycinewithriskofcardiometabolicdiseases AT zengl assessingthecausalassociationofglycinewithriskofcardiometabolicdiseases AT erdmannj assessingthecausalassociationofglycinewithriskofcardiometabolicdiseases AT schunkerth assessingthecausalassociationofglycinewithriskofcardiometabolicdiseases AT khawk assessingthecausalassociationofglycinewithriskofcardiometabolicdiseases AT griffinj assessingthecausalassociationofglycinewithriskofcardiometabolicdiseases AT forouhin assessingthecausalassociationofglycinewithriskofcardiometabolicdiseases AT scottr assessingthecausalassociationofglycinewithriskofcardiometabolicdiseases AT wooda assessingthecausalassociationofglycinewithriskofcardiometabolicdiseases AT burgesss assessingthecausalassociationofglycinewithriskofcardiometabolicdiseases AT howsonj assessingthecausalassociationofglycinewithriskofcardiometabolicdiseases AT daneshj assessingthecausalassociationofglycinewithriskofcardiometabolicdiseases AT warehamn assessingthecausalassociationofglycinewithriskofcardiometabolicdiseases AT butterwortha assessingthecausalassociationofglycinewithriskofcardiometabolicdiseases AT langenbergc assessingthecausalassociationofglycinewithriskofcardiometabolicdiseases |